The Journal of Immunology, Vol 141, Issue 5 1652-1657, Copyright © 1988 by American Association of Immunologists

ARTICLES

Adenosine, deoxyadenosine, and deoxyguanosine induce DNA cleavage in mouse thymocytes

H Kizaki, H Shimada, F Ohsaka and T Sakurada
Department of Biochemistry, School of Medicine, Keio University, Tokyo, Japan.

When thymocytes were cultured with adenosine, deoxyadenosine, or deoxyguanosine at 1 mM for 24 h, DNA cleavage at internucleosomal sites with multiples of approximately 180 bp was induced, followed by lactate dehydrogenase release into the medium. In the presence of coformycin, an adenosine deaminase inhibitor, or formycin B, a purine nucleoside phosphorylase inhibitor, DNA cleavage was induced by these nucleosides at concentrations of less than 50 microM. Other purine and pyrimidine ribo- and deoxyribonucleosides did not induce DNA cleavage or LDH release. Because thymocyte nuclei contain a Ca2+,Mg2+-dependent endonuclease, which preferentially cuts DNA in its linker regions, DNA fragmentation induced by the three purine nucleosides was suggested to occur through increased activity of the endonuclease. The DNA cleavage induced by the nucleosides required protein phosphorylation and synthesis, inasmuch as it was inhibited by an inhibitor of protein kinases, H-7, and by an inhibitor of protein synthesis, cycloheximide. The inhibition of DNA cleavage was accompanied by a reduction in lactate dehydrogenase release, suggesting a causal relationship between DNA cleavage and cell death. The DNA cleavage and subsequent cell lysis might be related to the selective thymocyte deletion observed in patients with adenosine deaminase or purine nucleoside phosphorylase deficiency.

This article has been cited by other articles:

				S. A. Gordon, W. Abou-Jaoude, R. A. Hoffman, S. A. McCarthy, Y.-M. Kim, X. Zhou, X.-R. Zhang, R. L. Simmons, Y. Chen, L. Schall, et al. Nitric oxide induces murine thymocyte apoptosis by oxidative injury and a p53-dependent mechanism J. Leukoc. Biol., July 1, 2001; 70(1): 87 - 95. [Abstract] [Full Text] [PDF]

				E. Richard, F. X. Arredondo-Vega, I. Santisteban, S. J. Kelly, D. D. Patel, and M. S. Hershfield The Binding Site of Human Adenosine Deaminase for CD26/Dipeptidyl Peptidase IV: The Arg142Gln Mutation Impairs Binding to CD26 but Does Not Cause Immune Deficiency J. Exp. Med., October 30, 2000; 192(9): 1223 - 1236. [Abstract] [Full Text] [PDF]

				C. P. Barry and S. E. Lind Adenosine-mediated Killing of Cultured Epithelial Cancer Cells Cancer Res., April 1, 2000; 60(7): 1887 - 1894. [Abstract] [Full Text]

				M. R. Dusing, A. G. Brickner, M. B. Thomas, and D. A. Wiginton Regulation of Duodenal Specific Expression of the Human Adenosine Deaminase Gene J. Biol. Chem., October 17, 1997; 272(42): 26634 - 26642. [Abstract] [Full Text] [PDF]

				M. Koshiba, H. Kojima, S. Huang, S. Apasov, and M. V. Sitkovsky Memory of Extracellular Adenosine A2A Purinergic Receptor-mediated Signaling in Murine T Cells J. Biol. Chem., October 10, 1997; 272(41): 25881 - 25889. [Abstract] [Full Text] [PDF]

				F. F. Snyder, J. P. Jenuth, E. R. Mably, and R. K. Mangat Point mutations at the purine nucleoside phosphorylase locus impair thymocyte differentiation in the mouse PNAS, March 18, 1997; 94(6): 2522 - 2527. [Abstract] [Full Text] [PDF]

				D. J McConkey At least two ways to apoptose: The 2-chlorodeoxyadenosine-induced cell death signalling pathway in human thymocytes is different from that induced by 2-chloroadenosine Szondy Z Biochemical Journal, 1995; 311: 585 - 588 Human and Experimental Toxicology, March 1, 1996; 15(3): 274 - 276. [PDF]